secwatch.observer — SEC 8-K summary
======================================

Issuer:     TScan Therapeutics, Inc. (TCRX)
CIK:        0001783328
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001193125-25-154336
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TScan Therapeutics holds annual meeting; elects three Class I directors and ratifies auditor
--------------------------------------------------------------------------------

- Elected Stephen Biggar, Gavin MacBeath, and Garry Nicholson as Class I directors for three-year terms through 2028.
- Garry Nicholson received 25.65M votes for and 5.86M withheld; Biggar and MacBeath each received >31M votes for.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 45.72M votes for, 64K against, 36K abstain.
- Broker non-votes totaled 14.31M on director elections, indicating some institutional abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783328/000119312525154336/0001193125-25-154336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783328/000119312525154336/d79904d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-154336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer